Metrovacesa S.A. (BME:MVC)
10.92
-0.20 (-1.80%)
Aug 3, 2026, 5:35 PM CET
Metrovacesa Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Metrovacesa stock has a consensus rating of "Sell" and an average price target of €10.73. The average 1-year stock price forecast is 1.74% lower than the current stock price, while the lowest is €9.30 (-14.84%) and the highest is €12.00 (+9.89%).
Price Target: €10.73 (-1.74%)
Analyst Consensus: Sell
Price Target
ChartAnalyst Ratings
The average analyst rating for Metrovacesa stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 1 |
| Total | 5 | 5 | 5 | 4 | 4 | 5 |
Financial Forecast
Revenue This Year
745.50M
from 708.37M
Increased by 5.24%
Revenue Next Year
781.00M
from 745.50M
Increased by 4.76%
EPS This Year
0.44
from 0.57
Decreased by -24.06%
EPS Next Year
0.45
from 0.44
Increased by 3.45%
EPS based on non-GAAP adjusted numbers. Financial currency is EUR.